CTMX vs HAL · rev $138.1M vs P/E 9.3, $19.05B cap
CytomX Therapeutics Inc (CTMX) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
HAL does not have a complete income-statement cache yet.
CTMX currently screens at market cap $653.1M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CTMX and HAL stock pages for the full models.
Not investment advice.